Due to rising costs and competition, the biopharma industry seeks cost, time, and resource savings while enhancing yield and quality. To stay competitive, therapeutic protein costs must drop below $50/gram. Global challenges like aging populations and climate change pressure the industry to meet sustainability targets. Sartorius' PI technologies offer solutions, enabling robust implementation. This panel will discuss managing information for effective PI implementation, maximizing operational value, and exploring industry perspectives on manufacturing technologies.
May 5, 14:30-15:15, room Marriott 1+2
| Name | Position | Institution |
|---|---|---|
| Geert Lissens | Head of PM Filtration & TFF Systems | Sartorius |
| Name | Position | Institution |
|---|---|---|
| Prof. Dr. Sonja Berensmeier | Chair of Bioseparation Engineering | TU Munich |
| Eduard Ayuso, DVM, PhD | Chief Technology Officer | Dinamiqs |
Simplifying Progress
Sartorius is a leading international partner of the biopharmaceutical industry. As a provider of innovative solutions with a broad product portfolio, we help our customers to manufacture biotech medications, such as cell and gene therapies, safely, rapidly, and sustainably.
Meet our experts:
- in the panel discussion on May 5, 14:30, Room 1+2 Marriott Hotel
- in the presentation on May 6, 15:30 - 15:45, Room: Osaka/Samarkand
- at our booth #101
